Ariad Announces Data Presentations At The European Hematology Association Congress

LAUSANNE, Switzerland, & VIENNA--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that clinical data on Iclusig® (ponatinib) will be presented at the 20th conference of the European Hematology Association (EHA) being held in Vienna, Austria, June 11 to 14, 2015.

The schedule and meeting location for the sessions, together with the abstract information, are listed below:

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC